Welcome to YLOAN.COM
yloan.com » Health » Aarkstore Enterprise -the Future Of Parenteral Nutrition: Key Players, Disease Specific Opportunitie
Health Medical Acne Aerobics-Cardio Alternative Anti-Aging Build-Muscle Chronic-Illness Dental-Care Depression Diabetes Disability Exercise Eye-Care Fitness-Equipment Hair-Loss Medicine Meditation Nutrition Obesity Polution Quit-Smoking Sidha Supplements Yeast Infection H1N1 Swine Flu SARS herpes therapy panic surgeon hurts teeth remedies eliminate chiropractic arthritis ingredients syndrome binding anxiety surgery medication psychic dental reflux doctor relief premature emotional stress disorder implants wrinkles vision infection aging liposuction seattle stunning sweating hair treatment tinnitus

Aarkstore Enterprise -the Future Of Parenteral Nutrition: Key Players, Disease Specific Opportunitie

The Future of Parenteral Nutrition: Key players

, disease specific opportunities and market forecasts

In 2009, approximately 390,000 patients in the major markets of the US, EU and Canada used parenteral nutrition products, accounting for total product sales of $1.3b. Through 2014, the total number of parenteral nutrition users in will rise by 10.0% per year to 628,000 and sales will expand by 11.3% per year, reflecting only nominal annual price increases. Four manufacturers currently jockey for share in this closely held market: market leader Baxter, enteral and parenteral products suppliers Fresenius Kabi and B. Braun, and Hospira. Although the introduction of new parenteral solutions is infrequent, these four players are differentiating themselves through hardware improvements, expanded pediatric labeling, new product formats and enhanced systems and services for home use. This report investigates these market opportunities, as well as emerging product development trend such as combination products and products developed for specialized disease populations. In each region profiled -US, Canada and EU -it investigates near and long term opportunities as well as recent product launches. Finally, it summarizes these opportunities in the context of product development initiatives currently underway at the leading manufacturers.

This report investigates these market opportunities, as well as emerging product development trend such as combination products and products developed for specialized disease populations. In each region profiled US, Canada and EU it investigates near and long term opportunities as well as recent product launches.

Scope of this research


* Develop deeper insight into the size and growth of the US, Canadian and EU parenteral nutrition industry, as well as individual EU country markets.

* Understand key product development trends in the parenteral nutrition market and the R&D strategies of the major players.

* Identify short and long term market opportunities in each region.

* Anticipate future parenteral nutrition market needs in light of the drivers and restraints acting upon the market.

* Describes the major market drivers and restraints in the US, Canada and EU, with detail provided for Germany, France, UK, Italy, Spain & Poland

Research and analysis highlights

Growth will be driven by increasing usage as the populations in these regions continue to age and incidence of conditions associated with parenteral nutrition, such as cancer and gastrointestinal disease, rises.

The total US, Canadian and EU parenteral nutrition market reached $1.3b in 2009 and is growing by 11.3% per year to reach $2.3bn in 2014. In 2009, Baxter led the market with 29.5% share, followed by Fresenius Kabi with 28.7%, B. Braun Melsungen with 22.2% and Hospira with 16.9%.

Major near term opportunities for new products include improved hardware and accessories, and products developed for home use. Important new recent launches include the triple-chamber bag, which three of the top four manufacturers now offer.

Key reasons to purchase this research

* What are the regional differences between the parenteral markets in the US, Canada, Germany, France, UK, Italy, Spain and Poland?

* Which companies are current and future key players and what are the issues driving new product development?

* What is limiting greater parenteral nutrition usage and how are prescribing decisions made by clinicians?

* What emerging products could significantly impact parenteral nutrition sales & what new product initiatives are being pursued by the leading players?


* What will the size and growth of the global parenteral nutrition market be through 2014?

For more information, please contact :

http://www.aarkstore.com/reports/The-Future-of-Parenteral-Nutrition-Key-players-disease-specific-opportunities-and-market-forecasts-70479.html

by: aarkstore enterprise
BEST ON HAVING ELECTRONIC CIGARETTES What are the Symptoms of Bed Bugs Ways to Stop Heart Disease Try Indoor Grow Closets For Winter Gardening Gripping SilverandStuff Objects For Everybody Symptoms Of Liver Cancer Hot Sitz Bath - A Treatment Alternative For Hemorrhoids Fresh Healthy Vending, The health-conscious company Why ZMA (Zinc and Magnesium Aspartate) Is the Perfect Supplement For Athletes and Bodybuilders Symptoms And Signs of Mumps Moncler is a fashion trend in this winter Many people are in need Moncler jackets in winter season Designer winter coats are the epitome of an individual's status symbol
print
www.yloan.com guest:  register | login | search IP(216.73.216.180) California / Anaheim Processed in 0.018334 second(s), 7 queries , Gzip enabled , discuz 5.5 through PHP 8.3.9 , debug code: 42 , 4097, 61,
Aarkstore Enterprise -the Future Of Parenteral Nutrition: Key Players, Disease Specific Opportunitie Anaheim